Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00941421
Other study ID # BRD 09/5-G
Secondary ID
Status Terminated
Phase N/A
First received July 16, 2009
Last updated June 11, 2013
Start date September 2009
Est. completion date February 2013

Study information

Verified date June 2013
Source Nantes University Hospital
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the equivalence or not of diagnosis ability of oesophagal videocapsul versus oeso-gastro-duodenal fiber endoscopy in the screening of oesophagal varix.


Recruitment information / eligibility

Status Terminated
Enrollment 310
Est. completion date February 2013
Est. primary completion date February 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- 18< age< 80

- Diagnosis of a cirrhosis

- suspicion of portal hypertension without known diagnosis of a cirrhosis

- Able to give an inform consent

Exclusion Criteria:

Related to pouplation

- case history of cancer or oesophagal surgery

- case history of an ORL cancer

- case history of evolutive cancer

Related to pathology

- Previous fiberoptic endoscopy with OV diagnosis

- Less than 6 month since last fiberoptic endoscopy

Related to tested device

- clinical suspicion of oesophagal stenosis for a patient presenting a dysphagia to solids

- Zenker diverticuls attested

- clinical suspicion of small intestinal stenosis

- patient with pace-maker or any other inter device

- pregnant women

- deglutition troubles withfalse passage and/or conscience troubles

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms

  • Cirrhotic Patient With Suspicion of Portal Hypertension and in a OV Screening Context
  • Hypertension, Portal

Intervention

Device:
oesophagal videocapsule and oeso-gastro-duodenal fiberoptic endoscopy
each patient receive one OVC and one OGDFE the same day

Locations

Country Name City State
France CHU Angers Angers
France CH Avicenne Bobigny
France CH Beaujon Clichy
France CH Saint Philibert Lomme
France CH Lyon - Herriot Lyon
France Hôpital la conception Marseille
France CHU Nantes Nantes
France CH Cochin Paris
France CHU Bordeaux Pessac
France CHU Strasbourg Strasbourg
France CHU Toulouse - Purpan Toulouse

Sponsors (1)

Lead Sponsor Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Presence or not of oesophagal varix each fiberoptic endoscopy No
Secondary Presence of OV with red signs each exam No
Secondary Presence of big VO or VO with red signs diagnosed by the two exams each patient No
Secondary Discrimination threshold for OV prediction each exam No
Secondary analogical visual scale for tolerance of each exam 30 days after last exam No